Novartis AG

Novartis AG is a leading global pharmaceutical company headquartered in Basel, Switzerland. The company focuses on the research, development, manufacturing, and marketing of innovative prescription medicines, addressing a wide range of therapeutic areas including cardiovascular, renal and metabolic disorders, immunology, neuroscience, oncology, and hematology. Novartis’s product lineup features widely recognized brands such as Entresto, Cosentyx, Kisqali, Tasigna, and Zolgensma, among others. Its portfolio also spans important treatments for chronic conditions like heart failure, psoriasis, cancers, and rare genetic diseases. Novartis operates globally, serving patients and healthcare institutions through direct distribution to pharmacists, hospitals, government agencies, and managed care organizations. With a robust pipeline of marketed and investigational drugs, the company maintains a significant presence in both developed and emerging markets. Novartis is consistently ranked among the world’s largest pharmaceutical firms by revenue, underscoring its pivotal role in advancing healthcare and medical innovation worldwide.